Improving opioid substitution therapy in the acute hospital setting: implementation of a best practice guideline.

IF 2.1 Q4 HEALTH CARE SCIENCES & SERVICES
Michael Trent Herdman, Brihitejas Patel, Poppy Pierce, Vedika Apte, Zainab Mashal Hussain Wasti, James Norman, Agnes Niemet, Kate Robinson, Iona Martin, Marisha Wickremsinhe, Nerissa Tilouche, Adrian 'Bean' Noctor, Jennifer Scott, Dan Lewer, Adam Holland, Magdalena Harris, Michael Brown
{"title":"Improving opioid substitution therapy in the acute hospital setting: implementation of a best practice guideline.","authors":"Michael Trent Herdman, Brihitejas Patel, Poppy Pierce, Vedika Apte, Zainab Mashal Hussain Wasti, James Norman, Agnes Niemet, Kate Robinson, Iona Martin, Marisha Wickremsinhe, Nerissa Tilouche, Adrian 'Bean' Noctor, Jennifer Scott, Dan Lewer, Adam Holland, Magdalena Harris, Michael Brown","doi":"10.1136/bmjoq-2026-004153","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Delayed provision of opioid substitution therapy (OST) in acute hospitals contributes to patient distress, opioid withdrawal and discharge against medical advice (DAMA). We aimed to improve access to opioid substitution therapy (OST) for hospital inpatients, using the iHOST ('improving hospital opioid substitution therapy') clinical guidelines, developed through a deliberative consensus process in partnership with clinical, academic and peer experts with professional body oversight.</p><p><strong>Methods: </strong>This pre-post quality improvement study evaluates implementation of the iHOST guideline at a tertiary hospital serving inner city London, UK between 2021 and 2023. Clinical records of all patients administered OST in the 12 months before and 11 months after the policy's introduction were evaluated for measures of process (reducing urine drug screening, improving time-to-administration), balancing (avoiding emergency naloxone administration, avoiding increased mortality) and outcome (discharge against medical advice).</p><p><strong>Results: </strong>Among 259 patients pre-policy and 194 post-policy, the median time to first methadone dose fell from 18.1 hours to 14.8 hours and the proportion of patients waiting more than 24 hours reduced from 32% to 21% (OR 0.57, 95% CI 0.37 to 0.88). Urine drug screening was one-sixth as likely to be performed on admission. There was no change in the likelihood of discharge against medical advice, which occurred for 24% of admissions during both periods (p=0.96). Naloxone was required for only 2% of admissions (five pre-policy, four times post p=1.00), indicating no compromise of patient safety.</p><p><strong>Conclusions: </strong>Implementing the iHOST guideline successfully reduced unnecessary delays to methadone administration without increasing the risk of opioid toxicity. While high rates of DAMA, even after improving access to OST, point to an ongoing need for patient-centred engagement strategies, successful implementation of the iHOST guideline supports its wider use: it is now under evaluation in two additional hospitals, after which it will be optimised to assess its utility for nation-wide practice.</p>","PeriodicalId":9052,"journal":{"name":"BMJ Open Quality","volume":"15 3","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2026-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13343018/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Quality","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjoq-2026-004153","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Delayed provision of opioid substitution therapy (OST) in acute hospitals contributes to patient distress, opioid withdrawal and discharge against medical advice (DAMA). We aimed to improve access to opioid substitution therapy (OST) for hospital inpatients, using the iHOST ('improving hospital opioid substitution therapy') clinical guidelines, developed through a deliberative consensus process in partnership with clinical, academic and peer experts with professional body oversight.

Methods: This pre-post quality improvement study evaluates implementation of the iHOST guideline at a tertiary hospital serving inner city London, UK between 2021 and 2023. Clinical records of all patients administered OST in the 12 months before and 11 months after the policy's introduction were evaluated for measures of process (reducing urine drug screening, improving time-to-administration), balancing (avoiding emergency naloxone administration, avoiding increased mortality) and outcome (discharge against medical advice).

Results: Among 259 patients pre-policy and 194 post-policy, the median time to first methadone dose fell from 18.1 hours to 14.8 hours and the proportion of patients waiting more than 24 hours reduced from 32% to 21% (OR 0.57, 95% CI 0.37 to 0.88). Urine drug screening was one-sixth as likely to be performed on admission. There was no change in the likelihood of discharge against medical advice, which occurred for 24% of admissions during both periods (p=0.96). Naloxone was required for only 2% of admissions (five pre-policy, four times post p=1.00), indicating no compromise of patient safety.

Conclusions: Implementing the iHOST guideline successfully reduced unnecessary delays to methadone administration without increasing the risk of opioid toxicity. While high rates of DAMA, even after improving access to OST, point to an ongoing need for patient-centred engagement strategies, successful implementation of the iHOST guideline supports its wider use: it is now under evaluation in two additional hospitals, after which it will be optimised to assess its utility for nation-wide practice.

改善急性医院环境中的阿片类药物替代治疗:最佳实践指南的实施
背景:急性医院延迟提供阿片类药物替代治疗(OST)会导致患者痛苦,阿片类药物戒断和不遵医嘱出院(DAMA)。我们的目标是改善医院住院患者获得阿片类药物替代疗法(OST)的机会,使用iHOST(“改善医院阿片类药物替代疗法”)临床指南,该指南是通过与临床、学术和同行专家在专业机构监督下的协商一致过程制定的。方法:这项岗前质量改进研究评估了2021年至2023年间在英国伦敦市中心服务的一家三级医院实施iHOST指南的情况。对政策实施前12个月和实施后11个月接受OST治疗的所有患者的临床记录进行评估,以评估过程(减少尿液药物筛查、缩短给药时间)、平衡(避免紧急使用纳洛酮、避免死亡率上升)和结果(不遵医嘱出院)的措施。结果:在政策前259例患者和政策后194例患者中,第一次美沙酮剂量的中位时间从18.1小时下降到14.8小时,等待超过24小时的患者比例从32%下降到21% (OR 0.57, 95% CI 0.37 ~ 0.88)。在入院时进行尿液药物筛查的可能性为六分之一。不遵医嘱出院的可能性没有变化,在这两个时期有24%的入院患者不遵医嘱出院(p=0.96)。只有2%的入院患者需要纳洛酮(政策前5次,政策后4次p=1.00),表明没有损害患者安全。结论:iHOST指南的实施成功地减少了美沙酮给药的不必要延误,而没有增加阿片类药物毒性的风险。即使在改善OST的可及性之后,DAMA的高发生率表明仍需要以患者为中心的参与战略,但iHOST指南的成功实施支持了其更广泛的使用:目前正在另外两家医院对其进行评估,之后将对其进行优化,以评估其在全国实践中的效用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMJ Open Quality
BMJ Open Quality Nursing-Leadership and Management
CiteScore
2.20
自引率
0.00%
发文量
226
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书